Advertisement
Screener

WINDTREE THERAPEUTICS INC /DE/ (WINT) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

WINDTREE THERAPEUTICS INC /DE/ Increase (Decrease) in Other Operating Liabilities

WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Increase (Decrease) in Other Operating Liabilities of $7.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2021-03-29

  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was -$112.00K.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was $60.00K.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for the quarter ending 2019-06-30 was $35.00K.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for the quarter ending 2019-03-31 was $24.00K.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for fiscal 2019 was $7.00K, a 61.11% decline from fiscal 2018.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for fiscal 2018 was $18.00K.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for fiscal 2017 was -$10.00K, a 108.06% decline from fiscal 2016.
  • WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other operating liabilities for fiscal 2016 was $124.00K.
Period endIncrease (Decrease) in Other Operating Liabilities 1 monthIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 12 month
2019-12-31-$112.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
-$52.00K
derived: sum of 2 quarters · filed 2021-03-29
-$17.00K
derived: sum of 3 quarters · filed 2021-03-29
$7.00K
10-K · filed 2021-03-29
2019-09-30$60.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
$95.00K
derived: sum of 2 quarters · filed 2020-11-16
$119.00K
10-Q · filed 2020-11-16
2019-06-30$35.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$59.00K
10-Q · filed 2020-08-14
2019-03-31$24.00K
10-Q · filed 2020-05-13
2018-12-31$18.00K
10-K · filed 2020-04-03
2017-12-31-$10.00K
10-K/A · filed 2019-04-23
2016-12-31$124.00K
10-K · filed 2017-03-31
$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17
$0.00
derived: sum of 2 quarters · filed 2018-04-17
$124.00K
derived: sum of 3 quarters · filed 2018-04-17
$124.00K
10-K · filed 2018-04-17
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$124.00K
derived: sum of 2 quarters · filed 2017-11-14
$124.00K
10-Q · filed 2017-11-14
$111.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$124.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21
$124.00K
10-Q · filed 2017-08-21
$111.00K
derived: sum of 3 quarters · filed 2017-08-21
$108.00K
derived: sum of 4 quarters · filed 2017-08-21
2016-03-31$0.00
10-Q · filed 2016-05-12
-$13.00K
derived: sum of 2 quarters · filed 2017-03-31
-$16.00K
derived: sum of 3 quarters · filed 2017-03-31
-$153.00K
derived: sum of 4 quarters · filed 2017-03-31
2015-12-31-$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$16.00K
derived: sum of 2 quarters · filed 2017-03-31
-$153.00K
derived: sum of 3 quarters · filed 2017-03-31
-$126.00K
10-K · filed 2017-03-31
2015-09-30-$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-$140.00K
derived: sum of 2 quarters · filed 2016-11-14
-$113.00K
10-Q · filed 2016-11-14
-$86.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$137.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
-$110.00K
10-Q · filed 2016-08-10
-$83.00K
derived: sum of 3 quarters · filed 2016-08-10
-$56.00K
derived: sum of 4 quarters · filed 2016-08-10
2015-03-31$27.00K
10-Q · filed 2016-05-12
$54.00K
derived: sum of 2 quarters · filed 2016-05-12
$81.00K
derived: sum of 3 quarters · filed 2016-05-12
-$518.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$54.00K
derived: sum of 2 quarters · filed 2016-03-29
-$545.00K
derived: sum of 3 quarters · filed 2016-03-29
-$369.00K
10-K · filed 2016-03-29
2014-09-30$27.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$572.00K
derived: sum of 2 quarters · filed 2015-11-05
-$396.00K
10-Q · filed 2015-11-05
-$289.00K
derived: sum of 4 quarters · filed 2015-11-05
2014-06-30-$599.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$423.00K
10-Q · filed 2015-08-10
-$316.00K
derived: sum of 3 quarters · filed 2015-08-10
-$318.00K
derived: sum of 4 quarters · filed 2015-08-10
2014-03-31$176.00K
10-Q · filed 2015-05-11
$283.00K
derived: sum of 2 quarters · filed 2015-05-11
$281.00K
derived: sum of 3 quarters · filed 2015-05-11
$232.00K
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
$105.00K
derived: sum of 2 quarters · filed 2015-03-16
$56.00K
derived: sum of 3 quarters · filed 2015-03-16
$95.00K
10-K · filed 2015-03-16
2013-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$51.00K
derived: sum of 2 quarters · filed 2014-11-07
-$12.00K
10-Q · filed 2014-11-07
-$239.00K
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$49.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$10.00K
10-Q · filed 2014-08-07
-$237.00K
derived: sum of 3 quarters · filed 2015-03-16
-$253.00K
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31$39.00K
10-Q · filed 2014-05-12
-$188.00K
derived: sum of 2 quarters · filed 2015-03-16
-$204.00K
derived: sum of 3 quarters · filed 2015-03-16
-$221.00K
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$227.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
-$243.00K
derived: sum of 2 quarters · filed 2015-03-16
-$260.00K
derived: sum of 3 quarters · filed 2015-03-16
-$246.00K
10-K · filed 2015-03-16
2012-09-30-$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$33.00K
derived: sum of 2 quarters · filed 2013-11-12
-$19.00K
10-Q · filed 2013-11-12
-$21.00K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$17.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
-$3.00K
10-Q · filed 2013-08-08
-$5.00K
derived: sum of 3 quarters · filed 2014-03-17
-$21.00K
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$14.00K
10-Q · filed 2013-05-07
$12.00K
derived: sum of 2 quarters · filed 2014-03-17
-$4.00K
derived: sum of 3 quarters · filed 2014-03-17
-$10.00K
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$18.00K
derived: sum of 2 quarters · filed 2014-03-17
-$24.00K
derived: sum of 3 quarters · filed 2014-03-17
$55.00K
10-K · filed 2014-03-17
2011-09-30-$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
-$22.00K
derived: sum of 2 quarters · filed 2012-11-14
$57.00K
10-Q · filed 2012-11-14
$51.00K
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$73.00K
10-Q · filed 2012-08-14
$67.00K
derived: sum of 3 quarters · filed 2013-03-15
$50.00K
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$79.00K
10-Q · filed 2012-05-15
$73.00K
derived: sum of 2 quarters · filed 2013-03-15
$56.00K
derived: sum of 3 quarters · filed 2013-03-15
2010-12-31-$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
-$23.00K
derived: sum of 2 quarters · filed 2013-03-15
-$2.02M
10-K · filed 2013-03-15
2010-09-30-$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$2.01M
10-Q · filed 2011-11-14
2010-06-30-$1.99M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70